Prostatic ductal adenocarcinoma: a mini review

Area of Science:

• Uropathology
• Oncology
• Prostate Cancer Research

Background:

• Prostatic ductal adenocarcinomas (PDAC) are a recognized subtype of prostate cancer.
• These tumors can arise from either large periurethral or peripheral prostatic ducts.
• Understanding their origin and characteristics is crucial for accurate diagnosis.

Purpose of the Study:

• To describe the origin, histological patterns, and immunohistochemical features of prostatic ductal adenocarcinomas.
• To differentiate PDAC from other prostatic lesions and non-prostatic adenocarcinomas.
• To clarify the Gleason grading implications of PDAC.

Main Methods:

• Histopathological examination of prostatic tissue samples.
• Analysis of cellular morphology, architectural patterns (cribriform, papillary, solid, single glands, PIN-like).
• Immunohistochemical staining for prostate-specific antigen (PSA) and basal cell markers.

Main Results:

• PDAC exhibit tall columnar cells in various patterns, with a PIN-like pattern behaving as Gleason pattern 3.
• The majority of PDAC patterns are comparable to Gleason pattern 4 prostate cancer.
• A patchy basal cell layer is characteristic, and PSA expression is typically observed.

Conclusions:

• Prostatic ductal adenocarcinoma is a distinct entity with specific morphological and immunohistochemical features.
• Accurate identification is essential, as PDAC often corresponds to Gleason pattern 4.
• Distinguishing PDAC from mimickers like prostatic urethral polyps and other carcinomas is critical for patient management.